Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDI-988 in Healthy Adults After Challenge With Norovirus
NCT07198139Phase 2Completed
- Sponsor
- Cocrystal Pharma
- Start
- Feb 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CDI-988 in norovirus infection (3 arms), sponsored by Cocrystal Pharma. Primary endpoint: Incidence of norovirus-confirmed disease. Started Feb 2026; status: completed.
02
Drugs
CDI-988
03
Conditions
norovirus infection
Beyond the preview
Go deeper on NCT07198139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07198139.